Image CDC Coronavirus Disease 2019 – COVID 19, Alissa Eckert
The COVID-19 pandemic is growing exponentially. ImmPort presents an opportunity to leverage legacy studies on infectious diseases, including Influenza (over 100 studies) and other respiratory-like illnesses from diverse cohorts (e.g. age, race, gender) sourced from NIAID-sponsored programs and beyond. If you are interested in sharing your COVID research data through ImmPort please contact ImmPort_COVID19. The ImmPort team’s curation staff can provide assistance and guidance for data curation, loading and sharing.
Disease type | Assays |
---|---|
COVID-19 studies | ELISA |
Influenza studies | ELISA, ELISPOT, Flow Cytometry, HAI |
Respiratory-like illness studies | Flow cytometry, CyToF, RNA-seq, Transcription Profiling by Array |
Viral infectious disease studies | ELISA, ELISPOT, Flow cytometry, CyToF, HLA-Typing, RNA-seq, Transcription Profiling by Array |
COVID-19 new studies | ELISA, ELISPOT, Flow cytometry, CyToF, HLA-Typing, RNA-seq, Transcription Profiling by Array |